HLN
Haleon plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.60
−2.64%Leverage
- Debt / equity
- 0.50x
- Net debt / equity
- 0.45x
- Debt / assets
- 0.25x
- Debt / EBITDA
- 1.64x
- Net debt / EBITDA
- 1.47x
Liquidity & coverage
- Current ratio
- 0.69x
- Quick ratio
- 0.52x
- Cash ratio
- 0.13x
- Interest coverage
- 8.62x
- EBITDA / interest
- 9.81x
- Working capital
- -$2.6B
Cash & dividend
- FCF / debt
- 0.24x
- Cash flow / debt
- 0.28x
- Dividend per share
- $0.19
- Dividend yield
- 2.0%
- Dividend growth 1y
- +11.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026